A detailed history of Nicollet Investment Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nicollet Investment Management, Inc. holds 20,402 shares of IONS stock, worth $726,923. This represents 0.28% of its overall portfolio holdings.

Number of Shares
20,402
Previous 20,108 1.46%
Holding current value
$726,923
Previous $958,000 14.72%
% of portfolio
0.28%
Previous 0.36%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$40.06 - $51.86 $11,777 - $15,246
294 Added 1.46%
20,402 $817,000
Q2 2024

Aug 07, 2024

SELL
$36.45 - $47.7 $15,053 - $19,700
-413 Reduced 2.01%
20,108 $958,000
Q1 2024

May 02, 2024

BUY
$42.03 - $53.55 $451,612 - $575,394
10,745 Added 109.91%
20,521 $890,000
Q4 2023

Feb 12, 2024

BUY
$43.39 - $51.63 $48,076 - $57,206
1,108 Added 12.78%
9,776 $495,000
Q3 2023

Nov 09, 2023

SELL
$38.5 - $47.13 $3,465 - $4,241
-90 Reduced 1.03%
8,668 $393,000
Q2 2023

Aug 08, 2023

BUY
$34.73 - $43.33 $10,175 - $12,695
293 Added 3.46%
8,758 $359,000
Q1 2023

May 09, 2023

BUY
$33.58 - $41.2 $17,696 - $21,712
527 Added 6.64%
8,465 $303,000
Q4 2022

Feb 06, 2023

SELL
$37.12 - $46.52 $21,158 - $26,516
-570 Reduced 6.7%
7,938 $300,000
Q3 2022

Nov 08, 2022

BUY
$36.54 - $48.66 $2,411 - $3,211
66 Added 0.78%
8,508 $376,000
Q2 2022

Aug 11, 2022

BUY
$31.71 - $43.0 $5,485 - $7,439
173 Added 2.09%
8,442 $313,000
Q1 2022

May 04, 2022

SELL
$29.88 - $37.04 $7,021 - $8,704
-235 Reduced 2.76%
8,269 $306,000
Q4 2021

Feb 09, 2022

SELL
$25.61 - $35.1 $51,143 - $70,094
-1,997 Reduced 19.02%
8,504 $259,000
Q3 2021

Nov 05, 2021

SELL
$33.54 - $40.55 $100 - $121
-3 Reduced 0.03%
10,501 $352,000
Q2 2021

Jul 28, 2021

SELL
$34.54 - $47.25 $10,603 - $14,505
-307 Reduced 2.84%
10,504 $419,000
Q1 2021

May 10, 2021

SELL
$42.51 - $63.78 $2,465 - $3,699
-58 Reduced 0.53%
10,811 $486,000
Q4 2020

Feb 09, 2021

BUY
$45.3 - $60.27 $23,012 - $30,617
508 Added 4.9%
10,869 $615,000
Q3 2020

Nov 10, 2020

SELL
$47.45 - $62.95 $1,376 - $1,825
-29 Reduced 0.28%
10,361 $492,000
Q2 2020

Aug 04, 2020

BUY
$46.85 - $61.05 $18,037 - $23,504
385 Added 3.85%
10,390 $613,000
Q1 2020

May 04, 2020

SELL
$41.6 - $63.4 $13,936 - $21,239
-335 Reduced 3.24%
10,005 $473,000
Q4 2019

Feb 07, 2020

SELL
$53.85 - $65.27 $15,616 - $18,928
-290 Reduced 2.73%
10,340 $625,000
Q3 2019

Nov 12, 2019

BUY
$59.06 - $72.15 $4,429 - $5,411
75 Added 0.71%
10,630 $637,000
Q2 2019

Aug 09, 2019

SELL
$62.09 - $86.14 $4,346 - $6,029
-70 Reduced 0.66%
10,555 $678,000
Q1 2019

May 02, 2019

BUY
$52.92 - $81.17 $1,587 - $2,435
30 Added 0.28%
10,625 $862,000
Q4 2018

Feb 11, 2019

SELL
$43.37 - $59.54 $4,120 - $5,656
-95 Reduced 0.89%
10,595 $573,000
Q3 2018

Nov 13, 2018

BUY
$42.88 - $53.7 $18,652 - $23,359
435 Added 4.24%
10,690 $551,000
Q2 2018

Aug 09, 2018

BUY
$40.53 - $50.7 $13,374 - $16,731
330 Added 3.32%
10,255 $427,000
Q1 2018

May 10, 2018

BUY
$44.08 - $55.05 $1,322 - $1,651
30 Added 0.3%
9,925 $437,000
Q4 2017

Feb 06, 2018

BUY
$50.3 - $64.39 $497,718 - $637,139
9,895
9,895 $498,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.06B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Nicollet Investment Management, Inc. Portfolio

Follow Nicollet Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicollet Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicollet Investment Management, Inc. with notifications on news.